Tevogen Bio Holdings (TVGN) Gains from Sales and Divestitures (2024 - 2026)
Tevogen Bio Holdings (TVGN) reported Gains from Sales and Divestitures of $8425.0 for Q1 2026, up 109.01% on a YoY basis from $4031.0 in Q1 2025, and down 58.21% quarter-over-quarter from $20159.0 in Q4 2025.
Tevogen Bio Holdings (TVGN) Gains from Sales and Divestitures (2024 - 2026) Analysis & Trends
Tevogen Bio Holdings has reported Gains from Sales and Divestitures for 3 years, with the latest figure at $8425.0 in Q1 2026.
- For the quarter ending Q1 2026, Gains from Sales and Divestitures rose 109.01% year-over-year to $8425.0; the trailing twelve-month figure through Mar 2026 stood at $8425.0 (up 109.01% YoY), and the FY2025 full-year result was $20159.0, down 49.6% from the prior year.
- Gains from Sales and Divestitures for Q1 2026 stood at $8425.0, down from $20159.0 in the prior quarter.
- The five-year high for Gains from Sales and Divestitures was $7.2 million in Q2 2024, with the low at $4031.0 in Q1 2025.
- Historically, Gains from Sales and Divestitures has averaged $2.3 million across 3 years, with a median of $40000.0 in 2024.
- The largest YoY upside for Gains from Sales and Divestitures was 47591.85% in 2025 against a maximum downside of 99.94% in 2025.
- Tevogen Bio Holdings' Gains from Sales and Divestitures stood at $40000.0 in 2024, then plunged by 49.6% to $20159.0 in 2025, then sank by 58.21% to $8425.0 in 2026.
- The last three Gains from Sales and Divestitures figures came in at $8425.0 (Q1 2026), $20159.0 (Q4 2025), and $5.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Tevogen Bio Holdings | 182.04 Mn | 181.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,425.00 |
| Mar 31, 2026 | 8,425.00 |
| Dec 31, 2025 | 20,159.00 |
| Dec 31, 2025 | 20,159.00 |
| Sep 30, 2025 | 5.72 Mn |
| Sep 30, 2025 | 5.72 Mn |
| Jun 30, 2025 | 216,398.00 |
| Jun 30, 2025 | 216,398.00 |
| Mar 31, 2025 | 4,031.00 |
| Mar 31, 2025 | 4,031.00 |
| Dec 31, 2024 | 40,000.00 |
| Dec 31, 2024 | 40,000.00 |
| Sep 30, 2024 | 12,000.00 |
| Sep 30, 2024 | 12,000.00 |
| Jun 30, 2024 | 7.17 Mn |
| Jun 30, 2024 | 7.17 Mn |
| Mar 31, 2024 | 7.15 Mn |
| Mar 31, 2024 | 7.15 Mn |